TBX4 and pulmonary arterial hypertension: The association of TBX4 variation and PAH was later uncovered in 2013 and the phenotype has since expanded to include developmental lung abnormalities including acinar dysplasia, pulmonary veno-occlusive disease, and a spectrum of interstitial lung diseases13–18.